These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28752843)

  • 1. Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.
    Le Guellec S; Macagno N; Velasco V; Lamant L; Lae M; Filleron T; Malissen N; Cassagnau E; Terrier P; Chevreau C; Ranchere-Vince D; Coindre JM
    Mod Pathol; 2017 Dec; 30(12):1677-1687. PubMed ID: 28752843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
    Schaefer IM; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Jan; 29(1):4-13. PubMed ID: 26585554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical evaluation of H3K27 trimethylation in malignant peripheral nerve sheath tumors.
    Otsuka H; Kohashi K; Yoshimoto M; Ishihara S; Toda Y; Yamada Y; Yamamoto H; Nakashima Y; Oda Y
    Pathol Res Pract; 2018 Mar; 214(3):417-425. PubMed ID: 29482987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone H3K27 dimethyl loss is highly specific for malignant peripheral nerve sheath tumor and distinguishes true PRC2 loss from isolated H3K27 trimethyl loss.
    Marchione DM; Lisby A; Viaene AN; Santi M; Nasrallah M; Wang LP; Williams EA; Larque AB; Chebib I; Garcia BA; Wojcik JB
    Mod Pathol; 2019 Oct; 32(10):1434-1446. PubMed ID: 31175328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of H3K27me3 Expression Is a Highly Sensitive Marker for Sporadic and Radiation-induced MPNST.
    Prieto-Granada CN; Wiesner T; Messina JL; Jungbluth AA; Chi P; Antonescu CR
    Am J Surg Pathol; 2016 Apr; 40(4):479-89. PubMed ID: 26645727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.
    Pekmezci M; Cuevas-Ocampo AK; Perry A; Horvai AE
    Mod Pathol; 2017 Dec; 30(12):1710-1719. PubMed ID: 28776579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of dimethylated H3K27 (H3K27me2) expression is not a specific marker of malignant peripheral nerve sheath tumor (MPNST): An immunohistochemical study of 137 cases, with emphasis on MPNST and melanocytic tumors.
    Thangaiah JJ; Westling BE; Roden AC; Giannini C; Tetzlaff M; Cho WC; Folpe AL
    Ann Diagn Pathol; 2022 Aug; 59():151967. PubMed ID: 35567887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
    Cleven AH; Sannaa GA; Briaire-de Bruijn I; Ingram DR; van de Rijn M; Rubin BP; de Vries MW; Watson KL; Torres KE; Wang WL; van Duinen SG; Hogendoorn PC; Lazar AJ; Bovée JV
    Mod Pathol; 2016 Jun; 29(6):582-90. PubMed ID: 26990975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.
    Mito JK; Qian X; Doyle LA; Hornick JL; Jo VY
    Am J Clin Pathol; 2017 Aug; 148(2):179-189. PubMed ID: 28898989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.
    Owosho AA; Estilo CL; Huryn JM; Chi P; Antonescu CR
    Head Neck Pathol; 2018 Jun; 12(2):151-159. PubMed ID: 28762137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond "Triton": Malignant Peripheral Nerve Sheath Tumors With Complete Heterologous Rhabdomyoblastic Differentiation Mimicking Spindle Cell Rhabdomyosarcoma.
    Hornick JL; Nielsen GP
    Am J Surg Pathol; 2019 Oct; 43(10):1323-1330. PubMed ID: 31107719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and prognostic significance of H3K27 methylation status in malignant peripheral nerve sheath tumor: correlation with skeletal muscle differentiation.
    Ito Y; Kohashi K; Endo M; Yoshimoto M; Ishihara S; Toda Y; Susuki Y; Kawaguchi K; Furukawa H; Tateishi Y; Yamada Y; Kinoshita I; Mori T; Yamamoto H; Nakashima Y; Oda Y
    Virchows Arch; 2021 Dec; 479(6):1233-1244. PubMed ID: 34432163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
    Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A
    Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors.
    Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P
    Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma.
    Zilla ML; John I; Naous R
    Int J Surg Pathol; 2024 Sep; 32(6):1089-1094. PubMed ID: 37997394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
    Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
    Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H3K27me3 expression and methylation status in histological variants of malignant peripheral nerve sheath tumours.
    Lyskjaer I; Lindsay D; Tirabosco R; Steele CD; Lombard P; Strobl AC; Rocha AM; Davies C; Ye H; Bekers E; Ingruber J; Lechner M; Amary F; Pillay N; Flanagan AM
    J Pathol; 2020 Oct; 252(2):151-164. PubMed ID: 32666581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.
    Asano N; Yoshida A; Ichikawa H; Mori T; Nakamura M; Kawai A; Hiraoka N
    Histopathology; 2017 Feb; 70(3):385-393. PubMed ID: 27580378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of H3K27me3 occurs in a large subset of embryonal rhabdomyosarcomas: Immunohistochemical and molecular analysis of 25 cases.
    Tomassen T; Kester LA; Tops BB; Driehuis E; van Noesel MM; van Ewijk R; van Gorp JM; Hulsker CC; Terwisscha-van Scheltinga SEJ; Merks HHM; Flucke U; Hiemcke-Jiwa LS
    Ann Diagn Pathol; 2021 Jun; 52():151735. PubMed ID: 33770660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications.
    Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ
    J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.